Clari Vest Asset Management LLC Corcept Therapeutics Inc Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	SELL	$12.27 - $15.65 $756,433 - $964,806	-61,649 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$15.3 - $19.69 $35,511 - $45,700	-2,321 Reduced 3.63%	61,649 $969,000
Q1 2018 May 08, 2018	SELL	$14.59 - $25.5 $1.33 Million - $2.33 Million	-91,300 Reduced 58.8%	63,970 $1.05 Million
Q4 2017 Feb 13, 2018	BUY	$15.77 - $20.72 $1.38 Million - $1.81 Million	87,349 Added 128.6%	155,270 $2.8 Million
Q3 2017 Nov 07, 2017	BUY	$12.3 - $19.3 $835,428 - $1.31 Million	67,921	67,921 $1.31 Million

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.